TGA Approval

AFINITOR everolimus 3 mg dispersible tablet blister pack (200204)

ARTG ID

200204

ARTG Name

AFINITOR everolimus 3 mg dispersible tablet blister pack

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

August 28, 2013

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

https://medical-cdn.nocode.com/drug_tga/d0b750f3ab0a56010c4f4a5005e8fc3d.pdf

https://medical-cdn.nocode.com/drug_tga/f78a81038f5e1d1d891de9b9ee597382.pdf

Ingredient Name

everolimus

Empowering clinical research with data-driven insights and AI-powered tools.

AFINITOR everolimus 3 mg dispersible tablet blister pack (200204) - TGA 批准文号 | MedPath